CVS Health Corporation (CVS)
| Market Cap | 80.04B |
| Revenue (ttm) | 370.66B |
| Net Income (ttm) | 4.61B |
| Shares Out | 1.26B |
| EPS (ttm) | 3.66 |
| PE Ratio | 17.34 |
| Forward PE | 10.76 |
| Dividend | $2.66 (4.19%) |
| Ex-Dividend Date | Jan 23, 2025 |
| Volume | 13,946,313 |
| Open | 62.88 |
| Previous Close | 65.09 |
| Day's Range | 62.02 - 65.29 |
| 52-Week Range | 43.56 - 80.75 |
| Beta | 0.61 |
| Analysts | Buy |
| Price Target | 69.75 (+9.88%) |
| Earnings Date | Feb 12, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $69.75, which is an increase of 9.88% from the latest price.
News
CVS cuts bonuses after low profit levels in 2024
CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare conglomerate grapples with higher costs across its Medicare plans.
Thermo Fisher Scientific Elects New Director to Board
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective Feb...
My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys
January saw solid investment activity with $1,500 in net capital added, primarily into Business Development Companies like Owl Rock Capital, Goldman Sachs BDC, and Blackstone Secured Lending Fund. Div...
Top 2 cheap stocks to buy for 2025
The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage levels. CVS' Q4 results showed a surprising EBIT margin beat, but continued ma...
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health pla...
Ed DeVaney named President of CVS Caremark
WOONSOCKET, R.I. , Feb. 17, 2025 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business.
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
CVS shares are up 45% this year — here's why it may be starting to turn its business around
CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and...
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Despite a >10% rise in CVS Health's stock price from my initial BUY recommendation, CVS Health is downgraded to Hold due to substantial political risks and declining cash flow. CVS faces significant c...
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
CVS Health's All-in-One App Aims to Personalize Healthcare
Digital personalization in the healthcare industry is critical to elevate the customer experience. In keeping with that theme, CVS Health CEO David Joyner identified advancing digital strategies as on...
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic" practices...
Trade Tracker: Joe Terranova buys CVS and Alibaba
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying these two stocks at these levels.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
CVS Health (CVS) Q4 2024 Earnings Call Transcript
DASH Feeds Bulls, UPST's Blowout Earnings, CVS Hits 4-Month High
DoorDash (DASH) managed a revenue beat and shared outlook that signaled bulls to buy. That company's rally didn't match Upstart's (UPST) 30% gain after it shared strong optimism on the quarter and its...
CVS stock rises 10% as company beats revenue estimates despite insurance cost pressures
CVS Health (NYSE: CVS) reported fourth-quarter earnings that exceeded analyst expectations on Wednesday, driven by strong sales in its pharmacy and insurance businesses. However, the company continues...
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
CVS's stock soars after a big profit beat, continued improvement in PBM business
CVS's stock soared toward a three-month high after its quarterly profit beat expectations by the widest margin in more than four years.
CVS results top estimates, even as high medical costs drag down insurance unit
CNBC's Becky Quick reports on the company's quarterly earnings results.
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as the pace of medical cost increases slowed at the healthcare conglomerate and revenues jumped in its pharmacy b...
CVS results top estimates even as high medical costs drag down insurance unit
CVS Health reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business saw higher medical costs. The company also issued a full-year 2025 adjusted profit...